 NEW YORK, May 7, 2021 PRNewswire -- Juan Monteverde , founder and managing partner at Monteverde Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Chiasma, Inc. CHMA or the Company CHMA relating to its proposed acquisition by Amryt Pharma plc. Under the terms of the agreement, CHMA shareholders will receive 0.396 Amryt American Depositary Share, each representative of five Amryt ordinary shares, per share they own. 